Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors.

Feldman, Darren R

Paclitaxel, Ifosfamide, and Cisplatin Efficacy for First-Line Treatment of Patients With Intermediate- or Poor-Risk Germ Cell Tumors. [electronic resource] - Journal of clinical oncology : official journal of the American Society of Clinical Oncology 07 2016 - 2478-83 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1527-7755

10.1200/JCO.2016.66.7899 doi


Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cisplatin--administration & dosage
Female
Humans
Ifosfamide--administration & dosage
Male
Middle Aged
Neoplasms, Germ Cell and Embryonal--drug therapy
Paclitaxel--administration & dosage
Prospective Studies